“…Theoretically, the ideal response to the presence of HPV infection without a cytologically confirmed precancer would be to repeat testing at an interval that takes into account the possibility of self-elimination of the most infections, for example, after 2 years. However, in practice, it is difficult for a woman and her doctor/health care provider to endure this period, primarily because of the risk of losing the possibility of observation, and therefore, at present, retesting after about 1 year is most often recommended [16,32]. In this case, possible sorting methods can include both cytology [17,23,33,34], and immunocytochemical dual stain cytology, which can assess as positive or negative (p16 / Ki-67 dual staining) [35], and HPV genotyping in various configurations [16,17,36], and other promising new technologies, including an automated cytological method that be programmed to provide a severity score (presented by Schiffman et al at the 30th International HPV Conference in 2015).…”